<?xml version='1.0' encoding='utf-8'?>
<document id="27964751"><sentence text="Neurotoxicity and nephrotoxicity caused by combined use of lithium and risperidone: a case report and literature review."><entity charOffset="59-66" id="DDI-PubMed.27964751.s1.e0" text="lithium" /><entity charOffset="71-82" id="DDI-PubMed.27964751.s1.e1" text="risperidone" /><pair ddi="false" e1="DDI-PubMed.27964751.s1.e0" e2="DDI-PubMed.27964751.s1.e0" /><pair ddi="false" e1="DDI-PubMed.27964751.s1.e0" e2="DDI-PubMed.27964751.s1.e1" /></sentence><sentence text="CombinationÂ lithium, a mood stabilizer, and risperidone, an atypical antipsychotic drug, is widely used for treatment of psychotic disorders"><entity charOffset="44-55" id="DDI-PubMed.27964751.s2.e0" text="risperidone" /></sentence><sentence text=" Rare reports concern severe adverse drug reaction in multiple organic systems with their combined use" /><sentence text=" We report two episodes of neurotoxicity and nephrotoxicity in a patient following the combined use of lithium and risperidone"><entity charOffset="103-110" id="DDI-PubMed.27964751.s4.e0" text="lithium" /><entity charOffset="115-126" id="DDI-PubMed.27964751.s4.e1" text="risperidone" /><pair ddi="false" e1="DDI-PubMed.27964751.s4.e0" e2="DDI-PubMed.27964751.s4.e0" /><pair ddi="false" e1="DDI-PubMed.27964751.s4.e0" e2="DDI-PubMed.27964751.s4.e1" /></sentence><sentence text="" /><sentence text="A 55-year-old male had a diagnosis of schizoaffective disorder at the age of 51" /><sentence text=" He was initially treated with a combination of lithium and olanzapine 5 to 15 mg/day for 2 years"><entity charOffset="48-55" id="DDI-PubMed.27964751.s7.e0" text="lithium" /><entity charOffset="60-70" id="DDI-PubMed.27964751.s7.e1" text="olanzapine" /><pair ddi="false" e1="DDI-PubMed.27964751.s7.e0" e2="DDI-PubMed.27964751.s7.e0" /><pair ddi="false" e1="DDI-PubMed.27964751.s7.e0" e2="DDI-PubMed.27964751.s7.e1" /></sentence><sentence text=" He was admitted to psychiatric ward at the age of 53 due to manic episode with psychotic feature" /><sentence text=" Because of poor blood sugar control, we switched olanzapine 20 mg/day to risperidone 4"><entity charOffset="23-28" id="DDI-PubMed.27964751.s9.e0" text="sugar" /><entity charOffset="50-60" id="DDI-PubMed.27964751.s9.e1" text="olanzapine" /><entity charOffset="74-85" id="DDI-PubMed.27964751.s9.e2" text="risperidone" /><pair ddi="false" e1="DDI-PubMed.27964751.s9.e0" e2="DDI-PubMed.27964751.s9.e0" /><pair ddi="false" e1="DDI-PubMed.27964751.s9.e0" e2="DDI-PubMed.27964751.s9.e1" /><pair ddi="false" e1="DDI-PubMed.27964751.s9.e0" e2="DDI-PubMed.27964751.s9.e2" /><pair ddi="false" e1="DDI-PubMed.27964751.s9.e1" e2="DDI-PubMed.27964751.s9.e1" /><pair ddi="false" e1="DDI-PubMed.27964751.s9.e1" e2="DDI-PubMed.27964751.s9.e2" /></sentence><sentence text="5 mg/day with combination of lithium 900mg/day"><entity charOffset="29-36" id="DDI-PubMed.27964751.s10.e0" text="lithium" /></sentence><sentence text=" The patient presented neurotoxicity, neuroleptic-malignant-syndrome like symptoms, and nephrotoxicity, elevation of blood creatinine and decreased urine output few days later"><entity charOffset="123-133" id="DDI-PubMed.27964751.s11.e0" text="creatinine" /></sentence><sentence text=" These signs were fully recovered within 2 days after we discontinued all medications and gave normal saline hydration" /><sentence text=" Then we re-administered decreased dosage of lithium 600 mg/day and risperidone 3 mg/day, and the similar episode occurred again 3 days later"><entity charOffset="45-52" id="DDI-PubMed.27964751.s13.e0" text="lithium" /><entity charOffset="68-79" id="DDI-PubMed.27964751.s13.e1" text="risperidone" /><pair ddi="false" e1="DDI-PubMed.27964751.s13.e0" e2="DDI-PubMed.27964751.s13.e0" /><pair ddi="false" e1="DDI-PubMed.27964751.s13.e0" e2="DDI-PubMed.27964751.s13.e1" /></sentence><sentence text=" All drugs were discontinued again, then his delirium resolved and abnormal data returned to normal 1 day later" /><sentence text=" Finally, the patient was treated with risperidone 2 mg/day as monotherapy, and no episode of neurotoxicity and nephrotoxicity appeared in the following 2 years"><entity charOffset="39-50" id="DDI-PubMed.27964751.s15.e0" text="risperidone" /></sentence><sentence text="" /><sentence text="The case exemplifies neurotoxicity and nephrotoxicity after combined use of lithium and risperidone"><entity charOffset="76-83" id="DDI-PubMed.27964751.s17.e0" text="lithium" /><entity charOffset="88-99" id="DDI-PubMed.27964751.s17.e1" text="risperidone" /><pair ddi="false" e1="DDI-PubMed.27964751.s17.e0" e2="DDI-PubMed.27964751.s17.e0" /><pair ddi="false" e1="DDI-PubMed.27964751.s17.e0" e2="DDI-PubMed.27964751.s17.e1" /></sentence><sentence text=" These adverse effects resolved soon after discontinuing these medications and adequate hydration" /><sentence text=" Clinicians should be cautious about neurological and renal adverse effects" /><sentence text="" /></document>